Mardia Samyoung Capillary Tubes Company Limited has released its unaudited standalone financial results for the quarter ended September 30, 2025, showing a significant reduction in net loss compared to the same period last year.

Financial Highlights

The company's financial performance shows a marked improvement in its bottom line, with the net loss narrowing by 86.47% year-over-year. While the revenue figures for the previous year were not provided, the current quarter's revenue from operations stood at ₹976.20 lakhs.

Operational Performance

The cash flow from operating activities for the six months ended September 30, 2025, showed a significant improvement. The negative cash flow reduced from ₹253.46 lakhs in the previous year to ₹3.48 lakhs, indicating better operational efficiency and working capital management.

Corporate Governance

The board of directors approved these financial results at a meeting held on November 11, 2025. SK Bhavsar Co., the statutory auditors, issued a limited review report with an unmodified opinion on the financial results, providing assurance on the accuracy of the reported figures.

Outlook

While the company continues to report a net loss, the substantial reduction in the loss figure and improved cash flow position suggest that Mardia Samyoung Capillary Tubes may be on a path to recovery. However, investors should note that these are unaudited results and may be subject to changes upon final audit.

The company's ability to sustain this trend of reducing losses and potentially achieve profitability in the coming quarters will be crucial for its financial health and market perception. Stakeholders will likely keep a close eye on future announcements and audited results to gauge the company's long-term prospects.

Note: All financial figures are based on standalone results and may not represent the complete financial position of the company if it has subsidiaries or associates.

MSCTC announced a significant change in its statutory auditor position. The company's current auditor, M/s Agrawal & Agrawal Associates, has resigned, citing pre-occupation with other professional work. This development has prompted MSCTC to appoint a new auditor to fill the vacancy.

Key Details of the Auditor Transition

New Auditor Appointment

The Board of Directors, based on the Audit Committee's recommendation, has approved the appointment of M/S. S K BHAVSAR & CO., Chartered Accountants (Firm's Registration No. 0145880W), as the new Statutory Auditors. This appointment is effective from November 3, 2025, and will continue until the conclusion of the ensuing General Meeting of the company.

About the New Auditor

M/s. S K BHAVSAR & CO. is described as a team of young, passionate, and energetic professionals offering cost-effective and high-technology services. Their expertise spans various areas including:

• Tax Consultancy
• Auditing & Assurance
• Accounts
• Corporate Laws
• Project Finance & Investment Consultancy

The firm provides these services across India, bringing a fresh perspective to MSCTC's financial oversight.

Company's Response

The Board of Directors has acknowledged the resignation of M/s Agrawal & Agrawal Associates and expressed appreciation for their guidance and contributions during their tenure as Statutory Auditor. The company has assured stakeholders that this change in auditors is part of normal corporate proceedings and does not impact the company's financial reporting integrity.

This transition in statutory auditors marks a significant corporate action for MSCTC. Shareholders and investors will likely be keen to see how this change might influence the company's financial reporting and auditing processes going forward.